Albarico, Jenica .
HRN: 23-93-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/14/2024
12/21/2024
IV
680mg
Q6h
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes